Eric Weisblum - 10 Dec 2021 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Weisblum
Issuer symbol: SILO
Transactions as of: 10 Dec 2021
Transactions value $: $3,187
Form type: 4
Filing time: 15 Dec 2021, 12:31:09 UTC
Previous filing: 17 May 2021
Next filing: 21 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$777	+5,000	+0.07%	$0.1554	7,694,063	10 Dec 2021	Direct
transaction	SILO	Common Stock	Purchase	$2,409	+17,500	+0.23%	$0.1377	7,711,563	13 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.131 to $0.1455. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.131 to $0.1455. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.